Physician profile
Mindy Pham
NPI 1518603810
$951.69
in general payments reported to CMS, 2019-2025
13 companies · $952 in 2025
The $952 reported for 2025 was more than what 85% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $952.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $952.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $951.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $393.48 | 2025 | |
| Novo Nordisk INC | $167.17 | 2025 | Ozempic, Wegovy, Rybelsus |
| Amgen INC. | $61.12 | 2025 | Otezla |
| Abbott Laboratories | $56.84 | 2025 | Freestyle Libre 3 |
| Pfizer INC. | $51.28 | 2025 | |
| Lilly USA, LLC | $46.14 | 2025 | Ebglyss, Taltz, Zepbound |
| Averitas Pharma INC. | $37.66 | 2025 | Qutenza |
| Exact Sciences Corporation | $37.34 | 2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Organogenesis INC. | $31.67 | 2025 | Via Matrix |
| Luye Pharma (USA) LTD. | $21.09 | 2025 | Erzofri Extended-Release |
| Sun Pharmaceutical Industries INC. | $18.87 | 2025 | |
| Janssen Biotech, INC. | $15.32 | 2025 | Tremfya |
| Arcutis Biotherapeutics, INC. | $13.71 | 2025 | Zoryve |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mindy Pham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.